Chief Operating Officer – Cool Laser Therapy Division
Overview:
Theralase® Technologies Inc. (“Theralase®”) is a publicly traded Canadian federal corporation (TSXV: TLT; OTCQB: TLTFF), which consists of two divisions; specifically:
1) The Anti-Cancer Therapy (“ACT”) division, which is a clinical stage, pre-commercialization research and development division dedicated to the research and development of Photo Dynamic Compounds (“PDCs”) and their associated drug formulations intended to safely and effectively destroy various cancers, bacteria and viruses, when light activated by proprietary medical laser systems.
2) The Cool Laser Therapy (“CLT”) division, which is a clinical stage, commercial division that designs, manufactures and distributes proprietary super-pulsed CLT medical lasers, primarily in Canada and the United States, for the treatment of knee pain, and in off-label use, treatment of numerous nerve, muscle and joint conditions. The CLT division also designs and manufactures the proprietary medical laser systems used to activate the PDCs in the ACT division.
Additional information is available at www.theralase.com and www.sedar.com
Description:
The successful candidate for the Chief Operating Officer – Cool Laser Therapy Division (“COO”) position will have 10+ years of hands-on operational experience in the triple digit revenue growth of a medical device division, through the leadership and hands-on management of multidisciplinary teams; specifically: marketing, sales, engineering, production and regulatory departments